Outcome and complications after implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy: systematic review and meta-analysis
about
Management of Patients With Cardiovascular Implantable Electronic Devices in Dental, Oral, and Maxillofacial SurgeryA systematic review of ICD complications in randomised controlled trials versus registries: is our 'real-world' data an underestimation?Risk Markers and Appropriate Implantable Defibrillator Therapy in Hypertrophic Cardiomyopathy.Oversensing of atrial fibrillatory waves in a subcutaneous implantable cardioverter-defibrillator.Living with hypertrophic cardiomyopathy and an implantable defibrillator.Health-related quality of life in hypertrophic cardiomyopathy patients with implantable defibrillators.Hypertrophic cardiomyopathy: The need for randomized trialsSudden cardiac death: a critical appraisal of the implantable cardioverter defibrillator.Almanac 2014: cardiomyopathies.Evaluating current implantable cardioverter defibrillator implantation procedures: can common complications be minimised?Pharmacological treatment of hypertrophic cardiomyopathy: current practice and novel perspectives.Prevention of sudden death in hypertrophic cardiomyopathy: bridging the gaps in knowledge.Rapid Device-Detected Nonsustained Ventricular Tachycardia in the Risk Stratification of Hypertrophic Cardiomyopathy.Myofilament protein dynamics modulate EAD formation in human hypertrophic cardiomyopathy.Appropriate Implantable Defibrillator Therapy in Adults With Hypertrophic Cardiomyopathy.Etiology and Programming Effects on Shock Efficacy in ICD Recipients.Hypertrophic Cardiomyopathy and Implantable Defibrillators in Sweden: Inappropriate Shocks and Complications Requiring Surgery.Implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy: an updated systematic review and meta-analysis of outcomes and complications.Risk assessment in hypertrophic cardiomyopathy: contemporary guidelines hampered by insufficient evidence.EvaLuation Using Cardiac Insertable Devices And TelephonE in Hypertrophic Cardiomyopathy (ELUCIDATE HCM)-rationale and design: a prospective observational study on incidence of arrhythmias in Sweden.Comparison of the Prognostic Usefulness of the European Society of Cardiology and American Heart Association/American College of Cardiology Foundation Risk Stratification Systems for Patients With Hypertrophic Cardiomyopathy.Patient understanding of disease and the use and outcome of implantable cardioverter defibrillators in hypertrophic cardiomyopathy.Pacing for hypertrophic obstructive cardiomyopathy: an update and future directions.Global longitudinal strain and left atrial volume index improve prediction of appropriate implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy patients.Safety, Efficacy and Evidence Base for Use of the Subcutaneous Implantable Cardioverter Defibrillator.Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy: What has Changed in The Guidelines?Relationship between Extension or Texture Features of Late Gadolinium Enhancement and Ventricular Tachyarrhythmias in Hypertrophic CardiomyopathyImplantable cardioverter-defibrillator in hypertrophic cardiomyopathy
P2860
Q28078483-1915BACF-BCA4-4072-A080-764D2D882724Q28082305-0C790578-25BA-46D4-AD30-52CE88F67C11Q33166584-4287C597-B78F-4BF3-915A-FD76C3170A67Q33643841-92625F5C-D311-4ABD-B0E5-780CF0B33294Q33655255-7BA31533-0F0D-4A22-ACFB-C8A275BE1AB4Q36800366-D577B5AD-A031-4FCC-8A0D-FD784C515CFCQ37659240-82A549EF-4C6D-447E-B04C-FB153FA5FC5AQ38174217-CCB5EFB2-404F-4619-80D1-038579CE00F4Q38193960-93146C69-DA99-4857-BC16-4652C2C98076Q38704127-C7BC57C9-4EA7-4288-9686-696B63546221Q38816364-ED007D7E-BAFC-41EE-B46D-C2D282BAA037Q38884022-A85D6C7C-3C68-4116-B13A-22BC093E5EDDQ38888427-2FECE604-FAA5-4E0C-9C82-45037BD07F5DQ39397322-7E6EABC9-A2CC-40F2-BD72-2BC706EA4CBBQ39801126-B9812AB2-00E7-4044-9759-B76580CC5591Q40450849-1F727E77-81C6-411A-A9A4-89AAA063DD12Q40732278-08FA04FB-5356-45AE-93C1-2D8E2BD5C367Q41698112-AB0F607C-CA78-4441-B49E-2E03E20B5471Q43217399-655C6A8D-3498-4085-8758-2DB3F6987561Q47132748-1069DBEA-25E1-4B72-BD09-2E0E9D845188Q47371803-247F12DF-F5DA-410D-973D-4093A31B682BQ47445769-32888B3C-F9CD-421A-B70E-3029AFBCECA5Q47857686-8C9FA209-2882-4A22-9020-3B6C39FC7D1DQ50623476-FE6A5A2A-13DC-4B2B-BDF6-3A4C09B8702EQ55412053-4FC22F1C-D463-48D7-AF5C-62530DE24D2AQ55427081-588F41C1-7E2F-48D5-9388-E1C66C7620B4Q57115246-DB494BB2-CEF0-4B64-BF14-9F32414C051EQ58565538-E979FB72-23F3-4FF2-BE2C-D97E45596240
P2860
Outcome and complications after implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy: systematic review and meta-analysis
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Outcome and complications afte ...... matic review and meta-analysis
@ast
Outcome and complications afte ...... matic review and meta-analysis
@en
Outcome and complications afte ...... matic review and meta-analysis
@nl
type
label
Outcome and complications afte ...... matic review and meta-analysis
@ast
Outcome and complications afte ...... matic review and meta-analysis
@en
Outcome and complications afte ...... matic review and meta-analysis
@nl
prefLabel
Outcome and complications afte ...... matic review and meta-analysis
@ast
Outcome and complications afte ...... matic review and meta-analysis
@en
Outcome and complications afte ...... matic review and meta-analysis
@nl
P31
P50
P3181
P1476
Outcome and complications afte ...... matic review and meta-analysis
@en
P2093
Arend F L Schinkel
Michelle Michels
P304
P3181
P356
10.1161/CIRCHEARTFAILURE.112.969626
P407
P577
2012-07-20T00:00:00Z